Technetium[99mTc] Monoclonal Antibody

锝[99mTc]人小细胞肺癌单抗片段

Report date: 2025/12/01 17:17:03

Base Information

Drug NameTechnetium[99mTc] Monoclonal Antibody
Drug Alias NameTc-99m-2F7 F（ab'）2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Radiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Technetium > 99mTc +[5] 
Mechanisms of ActionRadionuclide imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Cancer Institute
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Cancer Institute
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A